UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Indocyanine green angiographic documentation of regression of polypoidal lesions after brolucizumab injection in polypoidal choroidal vasculopathy

Indian journal of ophthalmology, 2023-07, Vol.3 (3), p.764

2023

Volltextzugriff (PDF)

Hyaluronic acid modified nanocarriers for aerosolized delivery of verteporfin in the treatment of acute lung injury

International journal of biological macromolecules, 2024-05, Vol.267 (Pt 1), p.131386-131386, Article 131386

2024

Volltextzugriff (PDF)

Sestrin2 attenuates renal damage by regulating Hippo pathway in diabetic nephropathy

Cell and tissue research, 2022-10, Vol.390 (1), p.93-112

2022

Volltextzugriff (PDF)

Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells

Free radical biology & medicine, 2024-02, Vol.212, p.493-504

2024

Volltextzugriff (PDF)

Verteporfin inhibits the dedifferentiation of tubular epithelial cells via TGF-β1/Smad pathway but induces podocyte loss in diabetic nephropathy

Life sciences (1973), 2022-12, Vol.311 (Pt B), p.121186-121186, Article 121186

2022

Volltextzugriff (PDF)

YAP1 silencing attenuated lung injury/fibrosis but worsened diaphragmatic function by regulating oxidative stress and inflammation response in mice

Free radical biology & medicine, 2022-11, Vol.193 (Pt 2), p.485-498

2022

Volltextzugriff (PDF)

Intracellularly Synthesized Artificial Exosome Treats Acute Lung Injury

ACS nano, 2024-08, Vol.18 (32), p.21009-21023

2024

Volltextzugriff (PDF)

SETD7 regulates chondrocyte differentiation and glycolysis via the Hippo signaling pathway and HIF-1[alpha]

International journal of molecular medicine, 2021-12, Vol.48 (6), p.1

2021

Volltextzugriff (PDF)

Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care

Acta ophthalmologica (Oxford, England), 2022-11, Vol.100 (7), p.e1522-e1532

2022

Volltextzugriff (PDF)

Targeted inhibition of YAP/TAZ alters the biological behaviours of keloid fibroblasts

Experimental dermatology, 2022-03, Vol.31 (3), p.320-329

2022

Volltextzugriff (PDF)

Regulation of H9C2 cell hypertrophy by 14-3-3[eta] via inhibiting glycolysis

PloS one, 2024-07, Vol.19 (7), p.e0307696

2024

Volltextzugriff (PDF)

Hippo pathway activation mediates chemotherapy-induced anti-cancer effect and cardiomyopathy through causing mitochondrial damage and dysfunction

Theranostics, 2023, Vol.13 (2), p.560-577

2023

Volltextzugriff (PDF)

FGF18–FGFR2 signaling triggers the activation of c-Jun–YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential

Oncogene, 2020-10, Vol.39 (43), p.6647-6663

2020

Volltextzugriff (PDF)

Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics

International journal of nanomedicine, 2019-01, Vol.14, p.10047-10060

2019

Volltextzugriff (PDF)

Verteporfin-loaded microparticles for radiosensitization of preclinical lung and breast metastatic spine cancer

Journal of neurosurgery. Spine, 2023-04, Vol.38 (4), p.481-493

2023

Volltextzugriff (PDF)

YAP inhibitor verteporfin suppresses tumor angiogenesis and overcomes chemoresistance in esophageal squamous cell carcinoma

Journal of cancer research and clinical oncology, 2023-08, Vol.149 (10), p.7703-7716

2023

Volltextzugriff (PDF)

Intracellular glutathione levels affect the outcomes of verteporfin-mediated photodynamic therapy in esophageal cancer cells

Photodiagnosis and photodynamic therapy, 2022-12, Vol.40, p.103090-103090, Article 103090

2022

Volltextzugriff (PDF)

Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer

Frontiers in immunology, 2023, Vol.14, p.1188087-1188087

2023

Volltextzugriff (PDF)

The YAP1 Signaling Inhibitors, Verteporfin and CA3, Suppress the Mesothelioma Cancer Stem Cell Phenotype

Molecular cancer research, 2020-03, Vol.18 (3), p.343-351

2020

Volltextzugriff (PDF)

Hippo/YAP1 inhibition by verteporfin attenuates osteophyte formation in a mouse surgical osteoarthritis model

Biomaterials advances, 2023-06, Vol.149, p.213413-213413, Article 213413

2023

Volltextzugriff (PDF)

Could the Length of the Alkyl Chain Affect the Photodynamic Activity of 5,10,15,20-Tetrakisporphyrins?

Molecules (Basel, Switzerland), 2024-03, Vol.29 (6)

2024

Volltextzugriff (PDF)

In-Vitro Use of Verteporfin for Photodynamic Therapy in Glioblastoma

Photodiagnosis and photodynamic therapy, 2022-12, Vol.40, p.103049-103049, Article 103049

2022

Volltextzugriff (PDF)

Verteporfin-Loaded Mesoporous Silica Nanoparticles' Topical Applications Inhibit Mouse Melanoma Lymphangiogenesis and Micrometastasis In Vivo

International journal of molecular sciences, 2021-12, Vol.22 (24), p.13443

2021

Volltextzugriff (PDF)

The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells

BMC cancer, 2024-05, Vol.24 (1), p.587-18, Article 587

2024

Volltextzugriff (PDF)

PIP5Kγ Mediates PIP2/Merlin/LATS1 Signaling Activation and Interplays with Hsc70 in Hippo–YAP Pathway Regulation

International journal of molecular sciences, 2023-09, Vol.24 (19)

2023

Volltextzugriff (PDF)

1 – 25 von 1.320

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.200)
Mit Volltextzugriff
(1.085)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.111)
Verteporfin
(1.097)
Life Sciences & Biomedicine
(1.031)
Humans
(765)
Photodynamic Therapy
(539)
Ophthalmology
(501)
Photochemotherapy
(420)
Photosensitizing Agents - Therapeutic Use
(403)
Female
(379)
Male
(365)
Porphyrins - Therapeutic Use
(330)
Visual Acuity
(265)
Fluorescein Angiography
(256)
Middle Aged
(253)
Aged
(251)
Animals
(249)
Choroidal Neovascularization - Drug Therapy
(206)
Treatment Outcome
(205)
Cancer
(198)
Photochemotherapy - Methods
(186)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Indocyanine green angiographic documentation of regression of polypoidal lesions after brolucizumab injection in polypoidal choroidal vasculopathy

Hyaluronic acid modified nanocarriers for aerosolized delivery of verteporfin in the treatment of acute lung injury

Sestrin2 attenuates renal damage by regulating Hippo pathway in diabetic nephropathy

Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells

Verteporfin inhibits the dedifferentiation of tubular epithelial cells via TGF-β1/Smad pathway but induces podocyte loss in diabetic nephropathy

YAP1 silencing attenuated lung injury/fibrosis but worsened diaphragmatic function by regulating oxidative stress and inflammation response in mice

Intracellularly Synthesized Artificial Exosome Treats Acute Lung Injury

SETD7 regulates chondrocyte differentiation and glycolysis via the Hippo signaling pathway and HIF-1[alpha]

Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care

Targeted inhibition of YAP/TAZ alters the biological behaviours of keloid fibroblasts

Regulation of H9C2 cell hypertrophy by 14-3-3[eta] via inhibiting glycolysis

Hippo pathway activation mediates chemotherapy-induced anti-cancer effect and cardiomyopathy through causing mitochondrial damage and dysfunction

FGF18–FGFR2 signaling triggers the activation of c-Jun–YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential

Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics

Verteporfin-loaded microparticles for radiosensitization of preclinical lung and breast metastatic spine cancer

YAP inhibitor verteporfin suppresses tumor angiogenesis and overcomes chemoresistance in esophageal squamous cell carcinoma

Intracellular glutathione levels affect the outcomes of verteporfin-mediated photodynamic therapy in esophageal cancer cells

Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer

The YAP1 Signaling Inhibitors, Verteporfin and CA3, Suppress the Mesothelioma Cancer Stem Cell Phenotype

Hippo/YAP1 inhibition by verteporfin attenuates osteophyte formation in a mouse surgical osteoarthritis model

Could the Length of the Alkyl Chain Affect the Photodynamic Activity of 5,10,15,20-Tetrakisporphyrins?

In-Vitro Use of Verteporfin for Photodynamic Therapy in Glioblastoma

Verteporfin-Loaded Mesoporous Silica Nanoparticles' Topical Applications Inhibit Mouse Melanoma Lymphangiogenesis and Micrometastasis In Vivo

The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells

PIP5Kγ Mediates PIP2/Merlin/LATS1 Signaling Activation and Interplays with Hsc70 in Hippo–YAP Pathway Regulation

Suchergebnisse filtern